Zaloguj się

Gotowe bibliografie tematyczne / Antiphospholipid syndrome / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Antiphospholipid syndrome.

Artykuły w czasopismach na temat „Antiphospholipid syndrome”

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 25 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Antiphospholipid syndrome”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Dutra, Livia Almeida, Pedro Braga-Neto, José Luiz Pedroso, and Orlando Graziani Povoas Barsottini. "Sneddon's syndrome: case report and review of its relationship with antiphospholipid syndrome." Einstein (São Paulo) 10, no. 2 (2012): 230–32. http://dx.doi.org/10.1590/s1679-45082012000200018.

Pełny tekst źródła

Streszczenie:

The Sneddon's syndrome is a rare disorder characterized by the occurrence of cerebrovascular disease associated with livedo reticularis. The antiphospholipid syndrome is the most frequent type of acquired thrombophilia, defined by the occurrence of thrombosis or pregnancy morbidity in the presence of persistently positive antiphospholipid antibodies. Approximately 80% of Sneddon's syndrome patients have an antiphospholipid antibody marker. These antibodies may play a pathogenetic role in some cases of Sneddon's syndrome, and many authors consider these two syndromes as the same entity. Althoug

Style APA, Harvard, Vancouver, ISO itp.

2

B, Aswin, Sumanth T, and Ravi Madhusudhana. "Pregnancy and Antiphospholipid Antibody Syndrome." Indian Journal of Anesthesia and Analgesia 9, no. 3 (2022): 41–43. http://dx.doi.org/10.21088/ijaa.2349.8471.9322.14.

Pełny tekst źródła

Streszczenie:

Introduction: ALPA is an autoimmune hypercoagulable state caused by antiphospholipid antibodies. It is characterized by thrombotic episodes in arteries, veins and pregnancy related complications like still birth, preterm delivery, miscarriage and severe preeclampsia. We report a case of APLA syndrome due to its rarity. Case Report: A 28 year old woman with a history of two previous abortions and positive serology for APLAs with 9 months gestation came to our hospital for safe confinement. She was diagnosed as primary APLA syndrome in view of bad obstetric history and positive lupus anticoagula

Style APA, Harvard, Vancouver, ISO itp.

3

Khamashta, Munther A., and Graham R. V. Hughes. "Antiphospholipid antibodies and antiphospholipid syndrome." Current Opinion in Rheumatology 7, no. 5 (1995): 389–94. http://dx.doi.org/10.1097/00002281-199509000-00005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Pavlovic, Dragan, and Aleksandra Pavlovic. "Antiphospholipid syndrome." Srpski arhiv za celokupno lekarstvo 138, no. 9-10 (2010): 651–57. http://dx.doi.org/10.2298/sarh1010651p.

Pełny tekst źródła

Streszczenie:

Antiphospholipid syndrome (APS) is an autoimmune disease with recurrent thromboses and pregnancy complications (90% are female patients) that can be primary and secondary (with concomitant autoimmune disease). Antiphospholipid antibodies are prothrombotic but also act directly with brain tissue. One clinical and one laboratory criterion is necessary for the diagnosis of APS. Positive serological tests have to be confirmed after at least 12 weeks. Clinical picture consists of thromboses in many organs and spontaneous miscarriages, sometimes thrombocytopaenia and haemolytic anaemia, but neurolog

Style APA, Harvard, Vancouver, ISO itp.

5

IKEDA, Yasuo. "Antiphospholipid Syndrome." Japanese Journal of Thrombosis and Hemostasis 2, no. 2 (1991): 112–21. http://dx.doi.org/10.2491/jjsth.2.112.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

ABE, Nobuya, and Tatsuya ATSUMI. "Antiphospholipid syndrome." Japanese Journal of Thrombosis and Hemostasis 29, no. 3 (2018): 294–306. http://dx.doi.org/10.2491/jjsth.29.294.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Santos, Thaís da Silva, Izabel Galhardo Demarchi, Tatiane França Perles Mello, Jorge Juarez Vieira Teixeira, and Maria Valdrinez Campana Lonardoni. "Antiphospholipid Syndrome." REVISTA CIÊNCIAS EM SAÚDE 9, no. 4 (2019): 37–42. http://dx.doi.org/10.21876/rcshci.v9i4.892.

Pełny tekst źródła

Streszczenie:

Antiphospholipid syndrome (APS) was characterized as an autoimmune condition with the production of antiphospholipid antibodies (aPL) associated with thrombosis and morbidity in pregnancy. The prevalence of aPL in the population ranges from 1% to 5% in patients with APS. The hypotheses regarding pathophysiological mechanisms are strongly related to binding proteins and antiphospholipid antibodies. The exact mechanisms by which they lead to clinical manifestations appear to be heterogeneous, but it is believed which aPL contribute to the cellular activation/coagulation, and so cause the thrombo

Style APA, Harvard, Vancouver, ISO itp.

8

ICHIKAWA, Kenji, Akito TSUTSUMI, Eiji MATSUURA, and Takao KOIKE. "Antiphospholipid Syndrome." Internal Medicine 38, no. 2 (1999): 170–73. http://dx.doi.org/10.2169/internalmedicine.38.170.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Makarenko, E. V. "ANTIPHOSPHOLIPID SYNDROME." Health and Ecology Issues, no. 4 (December 28, 2017): 4–11. http://dx.doi.org/10.51523/2708-6011.2017-14-4-1.

Pełny tekst źródła

Streszczenie:

Antiphospholipid syndrome is autoimmune acquired thrombophilia associated with the formation of antibodies to phospholipids, which is manifested by recurrent venous or arterial thrombosis and/or pathology of pregnancy. Antiphospholipid antibodies are a heterogeneous group of autoantibodies interacting with phospholipids, which are components of cell membranes and phospholipid-binding proteins of blood plasma. Antiphospholipid syndrome can affect vessels of any caliber and localization, with thrombosis accompanied by no morphological signs of inflammation in the wall of the vessel. Obstetrical

Style APA, Harvard, Vancouver, ISO itp.

10

Koike, Takao. "Antiphospholipid syndrome." Ensho 20, no. 5 (2000): 571–80. http://dx.doi.org/10.2492/jsir1981.20.571.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Arnout, Jef, and Milosz Jankowski. "Antiphospholipid syndrome." Hematology Journal 5 (2004): S1—S5. http://dx.doi.org/10.1038/sj.thj.6200412.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Jallow, T., D. D'Cruz, and H. Lempp. "Antiphospholipid syndrome." BMJ 350, apr02 3 (2015): h1426. http://dx.doi.org/10.1136/bmj.h1426.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Greaves, M. "Antiphospholipid syndrome." Journal of Clinical Pathology 50, no. 12 (1997): 973–74. http://dx.doi.org/10.1136/jcp.50.12.973.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Zuo, Yu, Hui Shi, Chun Li, and Jason S. Knight. "Antiphospholipid syndrome." Chinese Medical Journal 133, no. 8 (2020): 929–40. http://dx.doi.org/10.1097/cm9.0000000000000705.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Espinosa, Gerard, and Ricard Cervera. "Antiphospholipid syndrome." Arthritis Research & Therapy 10, no. 6 (2008): 230. http://dx.doi.org/10.1186/ar2536.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Asherson, Ronald A., and Ricard Cervera. "Antiphospholipid Syndrome." Journal of Investigative Dermatology 100, no. 1 (1993): 21S—27S. http://dx.doi.org/10.1111/1523-1747.ep12355193.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Nash, Michael J., and Hannah Cohen. "Antiphospholipid Syndrome." Medicine 30, no. 10 (2002): 31–32. http://dx.doi.org/10.1383/medc.30.10.31.28251.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Austin, Steven, and Hannah Cohen. "Antiphospholipid syndrome." Medicine 34, no. 11 (2006): 472–75. http://dx.doi.org/10.1053/j.mpmed.2006.08.012.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Alhasson, Hussam, Abdullah Abdullah, Amr Salama, Richard Alweis, and Timothy Woodlock. "Antiphospholipid Syndrome." American Journal of Therapeutics 27, no. 3 (2020): e328-e330. http://dx.doi.org/10.1097/mjt.0000000000000995.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

van Os, G. M. A., R. T. Urbanus, C. Agar, J. C. M. Meijers, and P. G. de Groot. "Antiphospholipid syndrome." Hämostaseologie 30, no. 03 (2010): 139–43. http://dx.doi.org/10.1055/s-0037-1619044.

Pełny tekst źródła

Streszczenie:

SummaryThe antiphospholipid syndrome (APS) is a non-inflammatory autoimmune disease characterized by the presence of antiphospholipid antibodies (aPL) in the plasma of patients with vascular thrombosis, recurrent complications of pregnancy, or both (1, 2). The presence of aPL in plasma of patients can be detected with either a prolongation of phospholipid dependent coagulation tests (lupus anticoagulant, LAC), or with solid phase immune assays against the protein β2-glycoprotein I (β2-GPI) or the phospholipid cardiolipin (anti-β2-GPI antibody ELISA and anti-cardiolipin antibody ELISA, respecti

Style APA, Harvard, Vancouver, ISO itp.

21

Danowski, Adriana, and Roger A. Levy. "Antiphospholipid syndrome." Revista Brasileira de Reumatologia (English Edition) 53, no. 2 (2013): 139–40. http://dx.doi.org/10.1016/s2255-5021(13)70018-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Cervera, Ricard. "Antiphospholipid syndrome." Thrombosis Research 151 (March 2017): S43—S47. http://dx.doi.org/10.1016/s0049-3848(17)30066-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Ruiz-Irastorza, Guillermo, Mark Crowther, Ware Branch, and Munther A. Khamashta. "Antiphospholipid syndrome." Lancet 376, no. 9751 (2010): 1498–509. http://dx.doi.org/10.1016/s0140-6736(10)60709-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Austin, Steven, and Hannah Cohen. "Antiphospholipid syndrome." Medicine 38, no. 2 (2010): 101–4. http://dx.doi.org/10.1016/j.mpmed.2009.10.012.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Jayakody Arachchillage, Deepa, and Hannah Cohen. "Antiphospholipid syndrome." Medicine 42, no. 3 (2014): 156–61. http://dx.doi.org/10.1016/j.mpmed.2013.12.001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Clark, Kristina E. N., and Ian Giles. "Antiphospholipid syndrome." Medicine 46, no. 2 (2018): 118–25. http://dx.doi.org/10.1016/j.mpmed.2017.11.006.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Petri, Michelle. "Antiphospholipid syndrome." Translational Research 225 (November 2020): 70–81. http://dx.doi.org/10.1016/j.trsl.2020.04.006.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Ravelli, Angelo, and Alberto Martini. "Antiphospholipid Syndrome." Pediatric Clinics of North America 52, no. 2 (2005): 469–91. http://dx.doi.org/10.1016/j.pcl.2005.01.001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Branch, D. Ware, and Munther A. Khamashta. "Antiphospholipid Syndrome." Obstetrics & Gynecology 101, no. 6 (2003): 1333–44. http://dx.doi.org/10.1097/00006250-200306000-00031.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Damron, Dana P. "Antiphospholipid Syndrome." Obstetrics & Gynecology 102, no. 4 (2003): 873. http://dx.doi.org/10.1097/00006250-200310000-00040.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Branch, Ware. "Antiphospholipid Syndrome." Obstetrics & Gynecology 102, no. 4 (2003): 873. http://dx.doi.org/10.1097/00006250-200310000-00041.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Gromnica-Ihle, Erika, and W. Schössler. "Antiphospholipid Syndrome." International Archives of Allergy and Immunology 123, no. 1 (2000): 67–76. http://dx.doi.org/10.1159/000024425.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Keswani, Sanjay C., and Naresh Chauhan. "Antiphospholipid Syndrome." Journal of the Royal Society of Medicine 95, no. 7 (2002): 336–42. http://dx.doi.org/10.1177/014107680209500705.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

George, Diane, and Doruk Erkan. "Antiphospholipid Syndrome." Progress in Cardiovascular Diseases 52, no. 2 (2009): 115–25. http://dx.doi.org/10.1016/j.pcad.2009.06.005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Nelson, Gregory N. "Antiphospholipid Syndrome." Journal of Hand Surgery 35, no. 11 (2010): 1890–92. http://dx.doi.org/10.1016/j.jhsa.2010.07.003.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Manson, J. J., and D. A. Isenberg. "Antiphospholipid syndrome." International Journal of Biochemistry & Cell Biology 35, no. 7 (2003): 1015–20. http://dx.doi.org/10.1016/s1357-2725(02)00313-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Corban, Michel T., Ali Duarte-Garcia, Robert D. McBane, Eric L. Matteson, Lilach O. Lerman, and Amir Lerman. "Antiphospholipid Syndrome." Journal of the American College of Cardiology 69, no. 18 (2017): 2317–30. http://dx.doi.org/10.1016/j.jacc.2017.02.058.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Gezer, Sefer. "Antiphospholipid syndrome." Disease-a-Month 49, no. 12 (2003): 696–741. http://dx.doi.org/10.1016/j.disamonth.2003.10.001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Khamashta, M., and G. R. Hughes. "Antiphospholipid syndrome." BMJ 307, no. 6909 (1993): 883–84. http://dx.doi.org/10.1136/bmj.307.6909.883.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Martinez, Alan P., and Mark T. Cunningham. "Antiphospholipid syndrome." Blood Coagulation & Fibrinolysis 27, no. 5 (2016): 557–62. http://dx.doi.org/10.1097/mbc.0000000000000550.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Annem, Chandrahasa, and Richard A. Furie. "Antiphospholipid Syndrome." JCR: Journal of Clinical Rheumatology 23, no. 5 (2017): 278–84. http://dx.doi.org/10.1097/rhu.0000000000000564.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

&NA;. "Antiphospholipid Syndrome." Obstetric Anesthesia Digest 26, no. 2 (2006): 52–53. http://dx.doi.org/10.1097/00132582-200606000-00008.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Asherson, Ronald A., and Ricard Cervera. "Antiphospholipid Syndrome." Journal of Investigative Dermatology 100, no. 1 (1993): S21—S27. http://dx.doi.org/10.1038/jid.1993.19.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Lim, Wendy. "Antiphospholipid syndrome." Hematology 2013, no. 1 (2013): 675–80. http://dx.doi.org/10.1182/asheducation-2013.1.675.

Pełny tekst źródła

Streszczenie:

Abstract The antiphospholipid syndrome (APS) is defined by venous or arterial thrombosis and/or pregnancy morbidity in patients with persistent presence of antiphospholipid antibodies (aPLs). Catastrophic APS is the most severe form of APS, which is associated with rapid development of microvascular thrombosis resulting in multiorgan failure in patients with aPLs. Patients with APS and catastrophic APS are recognized to have a high risk of recurrent thrombosis that can occur despite anticoagulant therapy. Although antithrombotic therapy remains the mainstay of treatment, bleeding manifestation

Style APA, Harvard, Vancouver, ISO itp.

45

Keswani, S. C., and N. Chauhan. "Antiphospholipid syndrome." JRSM 95, no. 7 (2002): 336–42. http://dx.doi.org/10.1258/jrsm.95.7.336.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Erkan, Doruk, and Michael D. Lockshin. "Antiphospholipid syndrome." Current Opinion in Internal Medicine 5, no. 4 (2006): 378–84. http://dx.doi.org/10.1097/01.bor.0000218943.89365.13.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Lau, CS. "Antiphospholipid Syndrome." Vascular Medicine Review vmr-5, no. 1 (1994): 33–45. http://dx.doi.org/10.1177/1358863x9400500104.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Vreede, Andrew P., Paula L. Bockenstedt, and Jason S. Knight. "Antiphospholipid syndrome." Current Opinion in Rheumatology 29, no. 5 (2017): 458–66. http://dx.doi.org/10.1097/bor.0000000000000410.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Khamashta, M., M. Taraborelli, S. Sciascia, and A. Tincani. "Antiphospholipid syndrome." Best Practice & Research Clinical Rheumatology 30, no. 1 (2016): 133–48. http://dx.doi.org/10.1016/j.berh.2016.04.002.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Sammaritano, Lisa R. "Antiphospholipid syndrome." Best Practice & Research Clinical Rheumatology 34, no. 1 (2020): 101463. http://dx.doi.org/10.1016/j.berh.2019.101463.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!